Low cerebral blood flow is associated with lower memory function in metabolic syndrome

Obesity

Volumn 21, Issue 7, 2013, Pages 1313-1320

  Birdsill, Alex C ^a,b   Carlsson, Cynthia M ^a,b   Willette, Auriel A ^c   Okonkwo, Ozioma C ^a,b   Johnson, Sterling C ^a,b   Xu, Guofan ^a,b   Oh, Jennifer M ^a,b   Gallagher, Catherine L ^a,b   Koscik, Rebecca L ^b   Jonaitis, Erin M ^b   Hermann, Bruce P ^b   Larue, Asenath ^b   Rowley, Howard A ^b   Asthana, Sanjay ^a,b   Sager, Mark A ^b   Bendlin, Barbara B ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGING; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN CORTEX; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; METABOLIC SYNDROME X; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; SPIN LABELING; TEMPORAL LOBE; TRIACYLGLYCEROL BLOOD LEVEL; VOXEL BASED MORPHOMETRY;

EID: 84881545230     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20170     Document Type: Article

References (39)

1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
2. Ervin RB,. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. 2009. National health statistics reports; no 13. National Center for Health Statistics: Hyattsville, MD: 2009.
3. Centers for Disease Control and Prevention and The Merck Company Foundation. The State of Aging and Health in America, 2007. Whitehouse Station, NJ: The Merck Company Foundation; 2007.
4. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J,. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006; 5: 735-741.
5. Vanhanen M, Koivisto K, Moilanen L, et al. Association of metabolic syndrome with Alzheimer disease. Neurology 2006; 67: 843-847.
6. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242.
7. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66: 336-342.
8. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L,. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 2009; 58: 71-77.
9. Frisardi V, Solfrizzi V, Seripa D, et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010; 9: 399-417.
10. Rogers RL, Meyer JS, McClintic K, Mortel KF,. Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion. Angiology 1989; 40: 260-269.
11. Muller M, van der Graaf Y, Visseren FL, Mali WP, Geerlings MI,. Hypertension and longitudinal changes in cerebral blood flow: The SMART-MR study. Ann Neurol 2012; 71: 825-833.
12. Carlsson CM, Xu G, Wen Z, et al. Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's Disease: a pilot study. Curr Alzheimer Res 2011;Epub ahead of print.
13. Willeumier KC, Taylor DV, Amen DG,. Elevated BMI is associated with decreased blood flow in the prefrontal cortex using SPECT imaging in healthy adults. Obesity (Silver Spring) 2011; 19: 1095-1097.
14. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005; 234: 851-859.
15. Sager MA, Hermann B, La Rue A,. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. J Geriatr Psychiatry Neurol 2005; 18: 245-249.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM,. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
17. Dowling NM, Hermann B, La Rue A, Sager MA,. Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease. Neuropsychology 2010; 24: 742-756.
18. Spreen O, Strauss E,. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 2nd edn. New York: Oxford University Press; 1998.
19. Wechsler D,. WAIS-III: Wechsler Adult Intelligence Scale. Psychological Corporation, 1997.
20. Trenerry MR,. Stroop Neuropsychological Screening Test Manual. Psychological Assessment Resources, 1989.
21. Reitan RM, Wolfson D,. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson: Neuropsychology Press, 1993.
22. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ,. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 2005; 19: 520-531.
23. Ye FQ, Frank JA, Weinberger DR, McLaughlin AC,. Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med 2000; 44: 92-100.
24. Dai W, Garcia D, de Bazelaire C, Alsop DC,. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008; 60: 1488-1497.
25. Garcia DM, Duhamel G, Alsop DC,. Efficiency of inversion pulses for background suppressed arterial spin labeling. Magn Reson Med 2005; 54: 366-372.
26. Xu G, Rowley HA, Wu G, et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed 2010; 23: 286-293.
27. Tosun D, Mojabi P, Weiner MW, Schuff N,. Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging. Neuroimage 2010; 52: 186-197.
28. Yakushev I, Hammers A, Fellgiebel A, et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 2009; 44: 43-50.
29. Ashburner J, Friston KJ,. Unified segmentation. Neuroimage 2005; 26: 839-851.
30. Keihaninejad S, Heckemann RA, Fagiolo G, Symms MR, Hajnal JV, Hammers A,. A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T). Neuroimage 2010; 50: 1427-1437.
31. Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage 2012; 59: 3774-3783.
32. O'brien R,. A Caution regarding rules of thumb for variance inflation factors. Qual Quan 2007; 41: 673-690.
33. MacKinnon DP, Fairchild AJ, Fritz MS,. Mediation analysis. Annu Rev Psychol 2007; 58: 593-614.
34. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094.
35. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005; 25: 7709-7717.
36. Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM,. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry 2002; 159: 738-745.
37. Craft S, Zallen G, Baker LD,. Glucose and memory in mild senile dementia of the Alzheimer type. J Clin Exp Neuropsychol 1992; 14: 253-267.
38. Yaffe K, Weston AL, Blackwell T, Krueger KA,. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009; 66: 324-328.
39. Wolk DA, Dickerson BC,. Fractionating verbal episodic memory in Alzheimer's disease. Neuroimage 2011; 54: 1530-1539.